使用这种方法，他们制成了治疗浸润性黑色素瘤的疫苗康维辛 （Canvaxin），这种疫苗中有20种不同的黑色素瘤肿瘤特异性成分，来把新的疾病识别方法教给人体。
The result was Canvaxin, a vaccine against aggressive melanoma that was loaded up with 20 different tumor-specific components of melanoma, teaching the body new ways to recognize the disease.
在这项研究中，研究人员对晚期黑色素瘤患者进行静脉注射4天白细胞介素- 2治疗后再注射疫苗或安慰剂。
In the study, people with advanced melanoma were given the vaccine or a placebo injection, followed by four days of intravenous interleukin-2 treatment.
有一种疫苗，肽类gp100：209-217（210M），体外实验已经显示出激活高水平的可以识别并攻击黑色素瘤细胞的T细胞。
One vaccine, the peptide gp100:209-217(210M), has been shown to elicit very high levels of T cells that recognize and attack melanoma cells in vitro.
应用推荐